Niferex (Avion Pharmaceuticals, LLC)
Welcome to the PulseAid listing for the Niferex drug offered from Avion Pharmaceuticals, LLC. This Iron [Chemical/Ingredient],Parenteral Iron Replacement [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA],Vitamin B 12 [Chemical/Ingredient],Vitamin B12 [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Avion Pharmaceuticals, LLC |
NON-PROPRIETARY NAME: | ferrous asparto glycinate, iron, ascorbic acid, folic acid, cyanocobalamin, zinc, succinic acid, and intrinsic factor |
SUBSTANCE NAME: | FERROUS ASPARTO GLYCINATE; IRON DEXTRAN; ASCORBIC ACID; LEVOMEFOLIC ACID; FOLIC ACID; CYANOCOBALAMIN; ZINC; SUCCINIC ACID; INTRINSIC FACTOR |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Iron [Chemical/Ingredient],Parenteral Iron Replacement [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA],Vitamin B 12 [Chemical/Ingredient],Vitamin B12 [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
START MARKETING DATE: | 2017-01-23 |
END MARKETING DATE: | 0000-00-00 |
Niferex HUMAN PRESCRIPTION DRUG Details:
Item Description | Niferex from Avion Pharmaceuticals, LLC |
LABELER NAME: | Avion Pharmaceuticals, LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50; 100; 60; 750; 250; 25; 15; 50; 100(mg/1; mg/1; mg/1; ug/1; ug/1; ug/1; mg/1; mg/1; mg/1) |
START MARKETING DATE: | 2017-01-23 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 75854-321_78267520-cb56-461e-9271-f1ffa21a8b26 |
PRODUCT NDC: | 75854-321 |
APPLICATION NUMBER: | |
Other FERROUS ASPARTO GLYCINATE; IRON DEXTRAN; ASCORBIC ACID; LEVOMEFOLIC ACID; FOLIC ACID; CYANOCOBALAMIN; ZINC; SUCCINIC ACID; INTRINSIC FACTOR Pharmaceutical Manufacturers / Labelers: